|
RND3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.996370E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.462400E-01 |
| Normal-vs-Stage2 |
5.624400E-04 |
| Normal-vs-Stage3 |
5.999400E-01 |
| Normal-vs-Stage4 |
7.450400E-01 |
| Stage1-vs-Stage2 |
1.036300E-03 |
| Stage1-vs-Stage3 |
5.120600E-01 |
| Stage1-vs-Stage4 |
4.518800E-01 |
| Stage2-vs-Stage3 |
1.395050E-03 |
| Stage2-vs-Stage4 |
1.742950E-03 |
| Stage3-vs-Stage4 |
8.461800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.848800E-01 |
| Normal-vs-AfricanAmerican |
5.247800E-01 |
| Normal-vs-Asian |
3.958600E-01 |
| Caucasian-vs-AfricanAmerican |
7.777000E-01 |
| Caucasian-vs-Asian |
6.354800E-01 |
| AfricanAmerican-vs-Asian |
9.971000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.672400E-01 |
| Normal-vs-Female |
1.977830E-01 |
| Male-vs-Female |
9.298200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.506400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.452400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.353800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.067400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.243180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.371800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.528000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.542000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.483600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.207200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.492800E-01 |
| Classical-VS-Follicular |
1.62447832963153E-12 |
| Classical-VS-Other |
5.309800E-01 |
| Classical-VS-Normal |
9.811000E-01 |
| Tall-VS-Follicular |
1.95517999999062E-05 |
| Tall-VS-Other |
3.084200E-01 |
| Tall-VS-Normal |
3.045600E-01 |
| Follicular-VS-Other |
4.802300E-03 |
| Follicular-VS-Normal |
1.21469999614376E-08 |
| Other-VS-Normal |
5.205400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.117600E-03 |
| Normal-vs-N1 |
6.921200E-01 |
| N0-vs-N1 |
9.402600E-03 |
|
|
